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Background
Strict avoidance of food allergens has been advised for
sensitization prevention and management. However,
recent studies suggest that is the early introduction of
food allergens, rather that avoidance, which might
induce tolerance.
Methods
January 2007-December 2009: 48 infants (< 1 year old)
were diagnosed in our Unit of IgE mediated CMA after
a complete evaluation (anamnesis and physical examina-
tion, skin prick test and specific serum IgE levels) Sub-
sequently, ALL patients underwent an open food
challenge (OFC). The OFC was postponed only in 1
case: a 4-month old boy with previous anaphylaxis
whose parents refused OFC until age one.
In the OFC, we do not look for reactions, but for a
well-tolerated dose as a starting point for reaching
tolerance.
Objectives
To evaluate the effectiveness and safety of our
performance.
Results
Most patients (44/48), presented a negative OFC (36/44)
or mild symptoms (2 oral allergy syndrome, 1 urticaria,
1 rhinoconjunctivitis, 4 vomiting) Subsequently, patients
underwent a gradual dose increase at home. Slower
increases for cases with mild/moderate symptoms were
recommended. The remaining patients (4/48), presented
a positive OFC (3/48 mild anaphylaxis) or persistent
symptoms in home dosing (1/48 daily vomiting). An
elimination diet was prescribed, followed by a second
challenge 3-6 months later ￿ it was negative in 2
patients, who continued gradual increases and a free
diet at age two, and positive in 2, who began a standar-
dized desensitization treatment.
Comments
Our results show the possibility for early management
in IgE mediated CMA. An early OFC, could be not only
ad i a g n o s t i ct o o lb u ta l s ot h eb e g i n n i n go ft h et r e a t -
ment, especially in infants: C o u l dad i a g n o s e di n f a n tb e
a treated infant?
Mild/moderate symptoms are common but usually
disappear with slower increases.
We believe that by anticipating clinical tolerance, we
could change the natural history of CMA in many
patients.
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